We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Behind-the-Counter-Drugs: New Life for an Old Idea?

January/February 2008

In light of recent events that have brought the idea of behind-the-counter (BTC) drugs back to the forefront at the FDA, including the agency's approval of BTC status for emergency contraceptive agent Plan B, the article examines the FDA's authority and history of practice regarding BTC drugs, as well as the future of BTC drugs.


Loading data